Efficacy, Safety and Tolerability of Different Bowel Preparation Before Colonoscopy in Children Over 2 Years Old
1 other identifier
interventional
315
1 country
1
Brief Summary
Electronic colonoscopy plays an important role in the diagnosis and follow-up of intestinal diseases in children.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2020
CompletedFirst Submitted
Initial submission to the registry
August 21, 2020
CompletedFirst Posted
Study publicly available on registry
August 25, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2021
CompletedOctober 11, 2021
October 1, 2021
10 months
August 21, 2020
October 8, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Bowel cleansing
Bowel cleansing was assessed by Boston bowel preparation scale (BBPS). The scores of left, middle and right colon were added up to the total score of BBPS, with the lowest score of 0 and the highest score of 9. The score of 8-9 represents excellent bowel preparation, 6-7 represents good, 4-5 represents average, and 0-3 represents poor. Excellent and good for intestinal preparation are qualified, general and poor for intestinal preparation are unqualified.
During the operation of electronic colonoscopy (about 15 min )
Secondary Outcomes (6)
Compliance with polyethylene glycol with electrolyte solution (PEG-ELS)
During bowel preparation (about 24 hours)
Adverse reactions receiving polyethylene glycol with electrolyte solution
During bowel preparation (about 24 hours)
Rate of nasal feeding PEG-ELS
During bowel preparation (about 24 hours)
Enema rate before colonoscopy
immediately before colonoscopy
Times of washing under colonoscopy
During the operation of electronic colonoscopy (about 15 mins)
- +1 more secondary outcomes
Study Arms (2)
PEG-ELS-S
EXPERIMENTALThe dosage of PEG-ELS is given according to body weight: 10-15 kg, PEG-ELS 0.75 L; 15-22.5 kg, PEG-ELS 1.5 L; 22.5-30 kg, PEG-ELS 2.25 L; more than 30 kg, PEG-ELS 3 L.
PEG-ELS-L
ACTIVE COMPARATORThe dosage of PEG-ELS is given according to body weight: 10-15 kg, PEG-ELS 0.75 L; 15-22.5 kg, PEG-ELS 1.5 L; 22.5-30 kg, PEG-ELS 2.25 L; more than 30 kg, PEG-ELS 3 L.
Interventions
2/3 dose of PEG-ELS was taken orally from the evening on the day before colonoscopy, and the remaining 1/3 dose of PEG-ELS was orally administered in the morning of the next day.
PEG-ELS is given orally on the day before colonoscopy, which is divided into 10-12 portions and taken one portion every hour. If half of the total amount is not completed at afternoon ward round the day before colonoscopy, nasogastric feeding is recommended.
Eligibility Criteria
You may qualify if:
- Newly diagnosed children in Department of Gastroenterology at Children's Hospital of Fudan University
- According to the indications of electronic colonoscopy, colonoscopy was performed for the first time
- Age: 2-22 years old
You may not qualify if:
- Having contraindications of electronic colonoscopy
- Having contraindications of general anesthesia
- Previous abdominal surgery
- Chronic constipation
- There is evidence of intestinal stenosis and gastrointestinal malformation
- Laxatives or drugs in the intestinal preparation protocol of this study have been used before bowel preparation
- Disagree the use of the bowel preparation protocol developed in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Children's hospital of Fudan university
Shanghai, Shanghai Municipality, 201102, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 21, 2020
First Posted
August 25, 2020
Study Start
August 1, 2020
Primary Completion
May 30, 2021
Study Completion
May 30, 2021
Last Updated
October 11, 2021
Record last verified: 2021-10
Data Sharing
- IPD Sharing
- Will not share